ClinicalTrials.gg
Not yet recruitingNCT07790393Updated Aug 27, 2026

Adductor Canal Block Versus Parasartorial Compartment Block for Pain Relief and Recovery After Arthroscopic Knee Surgery

An interventional study of Meperidine in Postoperative Pain After Arthroscopic Knee Surgery, sponsored by Istanbul Medipol University Hospital. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-27.

Sponsored by Istanbul Medipol University Hospital · Not applicable, Interventional, and Prevention

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 13 studies in Pain, Postoperative by Istanbul Medipol University Hospital — 4 open to participants now, 4 under way, none of them phase 3. Pain, Postoperative · Istanbul Medipol University Hospital.

Planned enrollment
10th of 13
60 · median 90
Started
2026
with 1 other
No phase
12 of 13
4 open now
Registered
11th of 13
by date

Among the 13 studies in Pain, Postoperative by Istanbul Medipol University Hospital, this one is the 10th largest by planned enrollment, is one of 2 that started in 2026, is one of 12 with no phase, and was the 11th registered.

Pain, Postoperative

5,662 studies on the registry are indexed under Pain, Postoperative; 1,238 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

4 of the 13 studies in Pain, Postoperative by Istanbul Medipol University Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 240 (35%) set no upper age limit and 328 (48%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Pain, Postoperative by Istanbul Medipol University Hospital, or all of them as a file.
02

Study summary

The goal of this clinical trial is to compare adductor canal block and parasartorial compartment block for pain relief and functional recovery in adults undergoing elective arthroscopic knee surgery. The main questions it aims to answer are:

Which block provides better pain relief at rest and during movement 24 hours after surgery? How do the two blocks compare in opioid use, muscle strength, knee movement, early walking, side effects, and patient satisfaction?

Researchers will compare participants who receive an adductor canal block with those who receive a parasartorial compartment block to determine whether one technique provides better pain relief and functional recovery while preserving muscle strength.

Participants will:

Be randomly assigned to receive either an ultrasound-guided adductor canal block or an ultrasound-guided parasartorial compartment block Have their pain at rest and during knee movement assessed for 48 hours after surgery Have their opioid use, quadriceps muscle strength, knee movement, walking ability, side effects, and satisfaction evaluated after surgery

03

Conditions studied

  • Postoperative Pain After Arthroscopic Knee Surgery

Browse trials for

Keywords

  • Adductor Canal Block
  • Postoperative Pain
  • Parasartorial Compartment Block
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Scheduled for elective unilateral primary arthroscopic knee surgery

Exclusion criteria

Exclusion Criteria:

  • Revision or bilateral arthroscopic knee surgery
  • Surgery performed for trauma or an emergency indication
  • to regional nerve block, including infection at the injection site, coagulopathy, or inappropriate anticoagulant use
  • Allergy to amide-type local anesthetics
  • Pre-existing peripheral neuropathy or motor deficit in the limb to be operated on
  • Dysfunction of the contralateral limb severe enough to interfere with functional assessments
  • Chronic opioid use
  • Severe cognitive impairment
  • Pregnancy or lactation
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Adductor Canal Block

    Drug: Meperidine

  • Active comparator
    Parasartorial Compartment Block

    Drug: Meperidine

Interventions

  • If the patient's NRS is 4 or more, 0.5 mg/kg meperidine will be given

06

What researchers measure

Primary outcomes

  1. Pain at Rest 24 Hours After Surgery

    Pain intensity at rest will be assessed using the Numeric Rating Scale, ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Lower scores indicate less pain.

    Time frame: 24 hours

07

Study locations

1 site
08

References and documents

Publications

  • Gungor H, Atalay YO. Para-sartorial compartments (Pasc) block for knee surgeries: a report of five cases. Minerva Anestesiol. 2023 Jun;89(6):606-608. doi: 10.23736/S0375-9393.23.17124-0. Epub 2023 Feb 8. No abstract available. PubMed 36752608 ↗
  • Pascarella G, Costa F, Del Buono R, Strumia A, Cataldo R, Agro F, Carassiti M. The para-sartorial compartments (PASC) block: a new approach to the femoral triangle block for complete analgesia of the anterior knee. Anaesth Rep. 2022 May 5;10(1):e12165. doi: 10.1002/anr3.12165. eCollection 2022 Jan-Jun. No abstract available. PubMed 35547556 ↗
  • Espelund M, Grevstad U, Jaeger P, Holmich P, Kjeldsen L, Mathiesen O, Dahl JB. Adductor canal blockade for moderate to severe pain after arthroscopic knee surgery: a randomized controlled trial. Acta Anaesthesiol Scand. 2014 Nov;58(10):1220-7. doi: 10.1111/aas.12407. PubMed 25307707 ↗
  • Chen B, Tan M, Li Q, Wang S, Chen D, Zhao M, Cao J. Application of ultrasound-guided single femoral triangle and adductor canal block in arthroscopic knee surgery: a prospective, double-blind, randomized clinical study. BMC Anesthesiol. 2024 May 23;24(1):182. doi: 10.1186/s12871-024-02555-0. PubMed 38783177 ↗

Individual participant data

Plan to share: No — Individual participant data will not be publicly shared because the informed consent process does not include consent for public data sharing and to protect participant confidentiality. Aggregated study results will be reported in scientific publications.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Jun 2027, 9 months later.

Of 2,101 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 9 months is below that.

Counting every sponsor, half of 2,114 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 25, 2026
First posted
Aug 27, 2026
StartEst.
Sep 2026
Primary completionEst.
Jun 2027
CompletionEst.
Jun 2027
Last update
Aug 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07790393
Responsible party
Fatma Pınar Uçar (M.D., Istanbul Medipol University Hospital) — Principal investigator
First posted
Aug 27, 2026
Start date
Sep 2026 (estimated)
Primary completion
Jun 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Aug 27, 2026

Study contacts

Fatma P Ucar, MD
Contact
fpinarucar@gmail.com
+905377697281

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Meperidine

Start the discussion